002: A Phase IIa Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/9/16 → 12/31/19

Funding

  • Reveragen Biopharma, Inc.